COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,731 Articles (22,502 medRxiv, 8,229 bioRxiv)

Most recent first Previous |  Page 156: Articles 1551-1560  | Next

Physiological modeling and biomechanical insights of cytokine modulation in COVID-19 and pulmonary fibrosis through graph-based approach
Ray, R., Bhowmik, R., Shyamal, S. S., Manaithiya, A., Gong, W., Parkkila, S., Aspatwar, A.
10.1101/2024.05.26.595932 — Posted: 2024-05-27
Estimating Re and overdispersion in secondary cases from the size of identical sequence clusters of SARS-CoV-2
Hodcroft, E. B., Wohlfender, M. S., Neher, R. A., Riou, J., Althaus, C. L.
10.1101/2024.05.26.24307940 — Posted: 2024-05-27
The hyperphosphorylation of SARS-CoV-2s nucleocapsid protein by GSK-3 involves a complex and redundant priming mechanism
Chen, S., He, Z., Kanyo, J., Lam, T., Ha, G., Lindenbach, B. D. D., Ha, Y.
10.1101/2024.05.25.595913 — Posted: 2024-05-27
Fine-scale spatial and social patterns of SARS-CoV-2 transmission from identical pathogen sequences
Tran-Kiem, C., Paredes, M. I., Perofsky, A. C., Frisbie, L. A., Xie, H., Kong, K., Weixler, A., Greninger, A. L., Roychoudhury, P., Peterson, J. M., Delgado, A., Holstead, H., MacKellar, D., Dykema, P., Gamboa, L., Frazar, C. D., Ryke, E., Stone, J., Reinhart, D., Starita, L., Thibodeau, A., Yun, C., Aragona, F., Black, A., Viboud, C., Bedford, T.
10.1101/2024.05.24.24307811 — Posted: 2024-05-25
Molnupiravir or nirmatrelvir-ritonavir versus usual care in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
Horby, P. W., Staplin, N., Peto, L., Emberson, J. R., Campbell, M., Pessoa-Amorim, G., Basnyat, B., Thwaites, L., Van Doorn, R., Hamers, R. L., Nel, J., Amuasi, J., Stewart, R., Ghosh, D., Hamilton, F., Desai, P., Easom, N., Majumdar, J., Hine, P., Chadwick, D., Cooke, G., Sharp, S., Esmail, H., Baillie, J. K., Buch, M. H., Faust, S. N., Jaki, T., Jeffery, K., Juszczak, E., Knight, M., Lim, W. S., Montgomery, A., Mukherjee, A., Mumford, A., Rowan, K., Thwaites, G., Mafham, M., Haynes, R., Landray, M. J.
10.1101/2024.05.23.24307731 — Posted: 2024-05-24
Detection of anti-nucleocapsid antibodies associated with primary SARS-CoV-2 infection in unvaccinated and vaccinated blood donors
Grebe, E., Stone, M., Spencer, B. R., Akinseye, A., Wright, D., Di Germanio, C., Bruhn, R., Zurita, K. G., Contestable, P., Green, V., Lanteri, M. C., Saa, P., Biggerstaff, B. J., Coughlin, M. M., Kleinman, S., Custer, B., Jones, J. M., Busch, M. P.
10.1101/2024.05.23.24307822 — Posted: 2024-05-24
Effects of the COVID-19 pandemic on individuals with Chemical Intolerance
Palmer, R. F., Kattari, D., Verduzco-Gutierrez, M.
10.1101/2024.05.23.24307835 — Posted: 2024-05-24
Minding the margins: Evaluating the impact of COVID-19 among Latinx and Black communities with optimal qualitative serological assessment tools
Binder, R. A., Matta, A. M., Forconi, C. S., Oduor, C. I., Bedekar, P., Patrone, P. N., Kearsley, A. J., Odwar, B. O., Batista, J., Forrester, S. N., Leftwich, H. K., Cavacini, L. A., Moormann, A. M.
10.1101/2024.05.23.24307817 — Posted: 2024-05-24
Immunogenicity and protective efficacy of an influenza virus-like particle-based SARS-CoV-2 hybrid vaccine candidate in rhesus macaques
Rahman, S. A., Bommireddy, R., Routhu, N. K., Lai, L., Pack, C. D., Ramachandiran, S., Suthar, M. S., Reddy, S. J. C., Selvaraj, P., Amara, R. R.
10.1101/2024.05.24.595657 — Posted: 2024-05-24
COVID-19 vaccination atlas: an integrative systems vaccinology approach
Prates-Syed, W. A., Fonseca, D. L. M., Zaki Pour, S., Filgueiras, I. S., Schimke, L. F., Lira, A. A., de Oliveira, N. C., Silva, J. D. Q., Carvalho, E., Chaves, L. C. S., Wunderlich, G., Duraes-Carvalho, R., Camara, N. O. S., Dias, H. D., Ochs, H. D., Sabino, E. C., Krieger, J. E., Nakaya, H. I., Cabral-Marques, O., Cabral-Miranda, G.
10.1101/2024.05.22.24307755 — Posted: 2024-05-23

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).